Business Wire

2022 SPIE and Photonics Media Prism Awards Celebrate Innovative Photonics Technologies

27.1.2022 09:10:00 EET | Business Wire | Press release

Share

Earlier this evening, following a festive reception during SPIE Photonics West, SPIE, the international society for optics and photonics, and Photonics Media recognized the top optics and photonics products on the market with their industry-focused Prism Awards.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220126005964/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

2022 SPIE and Photonics Media Prism Awards celebrate innovative photonics technologies at SPIE Photonics West. (Graphic: Business Wire)

The 14th annual ceremony showcased a dynamic range of companies — from Luxexcel, PlenOptika, and Lumotive, to SWIR, LightPath Technologies, and ColdQuanta — applying innovative and creative solutions to critical problems in areas such as augmented and virtual reality, biomedical devices, autonomous vehicles, quantum, and industrial lasers. In addition, the 2021 Prism Award winners of last year’s virtual ceremony were recognized in person at the beginning of the program.

Each year, the Prism Awards reflect the latest exciting developments, exponential growth, and rich technical innovations across photonics and photonics-enabled industries. For consideration in this year's awards, SPIE received 120 applications from 18 countries.

Finalists and winners were selected by a panel of international judges who leveraged the knowledge and acumen of leaders from across the technology commercialization and funding sectors. The distinguished judges’ roster included MKS Instruments’ Marc D. Himel, the FDA’s Zane Arp, Femto Blanc’s Uri Abrams, iFocus’ Adi Diner, Berkeley Catalyst Fund’s Laura Smoliar, Engender Technologies’ Cather Simpson, Luminate Accelerator’s Sujatha Ramanujan, Notal Vision’s Nishant Mohan, Teledyne Princeton Instruments’ Jason McClure, and Chromacity’s Shahida Imani.

"We are particularly delighted to be celebrating our Prism Award winners in person this year,” said SPIE CEO Kent Rochford. "These companies with their scientists and engineers — and I am including the award finalists as well — are ensuring that key technologies and products are reaching, energizing, and continually growing the photonics market. Their critical, innovative work is impacting lives across the globe.”

"Each year, the Prism Awards singles out the very brightest innovations in a highly innovative industry and, despite a global pandemic, supply chain issues, and other challenges over the past year, the 2022 winners still found a way to advance the field of photonics in important and remarkable ways,” said President and CEO of Photonics Media Tom Laurin. “We extend our congratulations to each of this year’s winners, who deserve our industry's recognition for their advancements in transportation, biomedicine, research, sensing, and quantum technology."

Below is the complete list of the award categories and the winners:

  • Augmented & Virtual Reality: Luxexcel
  • Autonomous Vehicles: Lumotive
  • Better Sensing: SWIR Vision Systems
  • Biomedical Devices: PlenOptika
  • Displays: BRELYON
  • Industrial Lasers: Civan Lasers
  • Manufacturing & Test: LightPath Technologies
  • Quantum: ColdQuanta
  • Scientific Lasers: Stuttgart Instruments
  • Software: Zemax

To find out more about the Prism Awards, please visit our website.

About Photonics Media

Photonics Media publishes print and digital business-to-business magazines, buyers' guides, websites, e-newsletters, webinars, virtual conferences, and podcasts for individuals working with light-based technologies in the photonics industry. A pioneering publisher in the discipline of photonics, Photonics Media has built a large global audience comprising academics and researchers, manufacturers, and end-users. Over the past six decades, the company has fostered a tradition of innovation that has defined the industry. As its publications grow — following the technology into an ever-widening range of applications — the company adheres to a philosophy of editorial quality and integrity, maintaining an international reputation for leadership in photonics. www.photonics.com.

About SPIE

SPIE, the international society for optics and photonics, brings engineers, scientists, students, and business professionals together to advance light-based science and technology. The Society, founded in 1955, connects and engages with our global constituency through industry-leading conferences and exhibitions; publications of conference proceedings, books, and journals in the SPIE Digital Library; and career-building opportunities. Over the past five years, SPIE has contributed more than $22 million to the international optics community through our advocacy and support, including scholarships, educational resources, travel grants, endowed gifts, and public-policy development. www.spie.org.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Daneet Steffens
Public Relations Manager
daneets@spie.org
+1 360 685 5478
@SPIEtweets

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Fujirebio and Sysmex Begin Sales Collaboration for Dementia Testing5.2.2026 08:30:00 EET | Press release

Fujirebio Holdings, Inc. (HQ: Minato-ku, Tokyo; President & CEO: Goki Ishikawa; “Fujirebio”), a consolidated subsidiary of H.U. Group Holdings, Inc. (HQ: Minato-ku, Tokyo; Chairman, President and Group CEO: Shigekazu Takeuchi) and Sysmex Corporation (HQ: Kobe, Japan; President: Kaoru Asano, “Sysmex”) have agreed on a sales collaboration for dementia testing. This agreement follows continued discussions based on the Basic Agreement on Business Collaboration in the Field of Immunoassay concluded in October 2023.1 Sysmex will exclusively sell Fujirebio's fully automated Lumipulse® immunoassay systems and dementia-related reagents ("the Products") in regions and countries mutually agreed upon by both companies. Going forward, Fujirebio and Sysmex will collaborate to meet the growing testing needs accompanying the wider adoption of therapeutic drugs and will gradually expand the countries where the Products are sold. Since entering into the Basic Agreement on Business Collaboration in Octob

Invivoscribe ® Launches LeukoStrat ® KMT2A + MRD Assay to Advance High-Sensitivity Leukemia Testing in Clinical Trials and Patient Management Worldwide5.2.2026 07:30:00 EET | Press release

Invivoscribe, a leader in precision medicine and measurable residual disease (MRD) testing, today announced the addition of the LeukoStrat®KMT2A + MRD Assay and Software to its industry-leading oncology portfolio. The assay leverages digital PCR (dPCR) to support both screening and precise longitudinal MRD monitoring for KMT2A rearrangements in acute myeloid leukemia (AML) subjects. This quantitative test is currently available for research use in clinical trials and as a stand-alone kit for purchase by our global customers, and will soon be available as a service in our regional LabPMM® laboratories worldwide. The assay is available to detect key AML-associated KMT2A rearrangements, which account for the vast majority of KMT2A fusion partners in AML1 and those most commonly targeted in menin-inhibitor clinical development programs. Later this year, the assay will be enhanced with four additional KMT2A rearrangements which are frequently found in acute lymphocytic leukemia (ALL), expan

VeriSilicon Enhanced ISP8200-FS Series IP Achieves ASIL B Functional Safety Certification5.2.2026 02:00:00 EET | Press release

VeriSilicon (688521.SH) today announced its latest enhanced versions of Image Signal Processing (ISP) IP ISP8200-FS series, ISP8200-ES and ISP8200L-ES, featuring improved performance and energy efficiency to better support complex automotive camera systems. These enhanced IPs have successfully achieved ISO 26262 ASIL B functional safety certifications issued by TÜV NORD, an international inspection and certification institution, further validating their suitability and reliability for ADAS and autonomous driving applications. The latest enhanced ISP8200-FS series IP can operate at up to 1.2 GHz and support data processing from up to 16 image sensors. It significantly improves the performance of multi-camera scheduling, enabling flexible data-access capabilities and efficient hardware pipeline utilization for automotive camera systems. The enhanced series IP integrates image processing technologies including Color Noise Reduction (CNR) and radial Lens Shading Correction (LSC), and featu

Mainstay Medical Announces Exclusive Coverage of ReActiv8® by Blue Cross Blue Shield of North Dakota4.2.2026 23:30:00 EET | Press release

Mainstay Medical Holdings plc today announced that Blue Cross Blue Shield of North Dakota has established favorable coverage for the company’s ReActiv8 Restorative NeurostimulationTM therapy for the treatment of intractable chronic low back pain. The policy went into effect in January 2026 and specifies that ReActiv8 is the only therapy considered medically necessary by the policy when the conditions for coverage are met. “We are pleased that another Blue Cross Blue Shield payer has joined Anthem in making ReActiv8 available to well-selected patients after reviewing the large body of clinical evidence we have built,”said Jason Hannon, CEO of Mainstay Medical. “Patients with intractable chronic low back pain are desperately seeking durable solutions, and ReActiv8 has proven to be a safe and effective solution through six clinical studies with 633 patients treated and 1,950 patient-years of follow-up, including two multi-center, randomized controlled clinical studies. We look forward to

Kinaxis Inc. to Host Fourth Quarter 2025 Financial Results Conference Call on March 5, 20264.2.2026 23:30:00 EET | Press release

Kinaxis® Inc. (TSX:KXS), a global leader in supply chain orchestration, today announced that it has scheduled its conference call to discuss the financial results for its fourth quarter and year ended December 31, 2025. The call will be hosted on Thursday, March 5 at 8:30 a.m. Eastern Time by Razat Gaurav, chief executive officer, and Blaine Fitzgerald, chief financial officer, followed by a question and answer period. The Company will report its financial results for the fourth quarter and year after the close of markets on Wednesday, March 4, 2026. CONFERENCE CALL DETAILS DATE: Thursday, March 5, 2026 TIME: 8:30 a.m. Eastern Time WEBCAST: https://events.q4inc.com/attendee/567578009 (available for three months) About Kinaxis Kinaxis is a leader in modern supply chain orchestration, powering complex global supply chains and supporting the people who manage them. Our powerful, AI-infused supply chain orchestration platform, Maestro, combines proprietary technologies and techniques that

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye